PDB_ID,Title,Protein_description,NChain,Chain_ID,Num_Res,Complex,Discarted_Ligands,Other_Entities,Ligand,Ligand_names,Ligand_types,Ligand_functions,Covalent_Bond,Bond,Mutation,Mutation_Location,Identity,Gaps
7tq5,Structure of SARS-CoV-2 3CL protease in complex with the cyclopropane based inhibitor 10d,3C-like proteinase,2,"A,B",309,Yes,"CL
PG4",,"IRW
ITX","(1S,2S)-1-hydroxy-2-{[N-({[(1R,2R)-2-(4-methoxyphenyl)cyclopropyl]methoxy}carbonyl)-L-leucyl]amino}-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid
(1R,2S)-1-hydroxy-2-{[N-({[(1R,2R)-2-(4-methoxyphenyl)cyclopropyl]methoxy}carbonyl)-L-leucyl]amino}-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid","non-polymer
non-polymer","
","Yes
Yes","CYS145 A; CYS145 B
CYS145 A; CYS145 B",None,None,None,None
7lke,X-ray crystal structure of the SARS-CoV-2 main protease in space group C2,3C-like proteinase,1,A,306,No,,,,,,,,,None,None,None,None
3e37,Protein farnesyltransferase complexed with bisubstrate ethylenediamine scaffold inhibitor 5,"Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha
Protein farnesyltransferase subunit beta",2,"A,B","379, 437",Yes,ZN,,"PRD_900003
ED5","beta-D-fructofuranose-(2-1)-alpha-D-glucopyranose
tert-butyl 4-({(2-{(4-cyanophenyl)[(1-methyl-1H-imidazol-5-yl)methyl]amino}ethyl)[(2-methylphenyl)sulfonyl]amino}methyl)piperidine-1-carboxylate","Oligosaccharide
non-polymer","Nutrient
","No
No","
","None
None","None
None","None
None","None
None"
5r7y,PanDDA analysis group deposition -- Crystal Structure of COVID-19 main protease in complex with Z45617795,3C-like proteinase,1,A,306,Yes,"DMS
CL",,JFM,N-(2-phenylethyl)methanesulfonamide,non-polymer,,No,,None,None,None,None
11gs,Glutathione s-transferase complexed with ethacrynic acid-glutathione conjugate (form ii),GLUTATHIONE S-TRANSFERASE,2,"A,B",210,Yes,"GSH
MES",,EAA,ETHACRYNIC ACID,non-polymer,,No,,None,None,None,None
1apw,CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION STATE MIMICS BOUND TO PENICILLOPEPSIN: DIFLUOROSTATINE-AND DIFLUOROSTATONE-CONTAINING PEPTIDES,PENICILLOPEPSIN,1,A,323,Yes,SO4,,"(IVA)VV(DFI)(NME)
MAN
HSY
DMF","INHIBITOR ISOVALERYL (IVA)-VAL-VAL-DIFLUOROSTATINE-N-METHYLAMINE
alpha-D-mannopyranose
alpha-L-xylopyranose
DIMETHYLFORMAMIDE","polypeptide(L)
D-saccharide, alpha linking
L-saccharide, alpha linking
non-polymer","


","No
(O-Glycosylation)
(GLYCOSYLATION SITE)
No","
SER3 A
THR7 A
",None,None,None,None
7aeg,"SARS-CoV-2 main protease in a covalent complex with SDZ 224015 derivative, compound 5",3C-like proteinase,1,A,305,Yes,DMS,,PRD_000338,N-[(benzyloxy)carbonyl]-L-valyl-N-[(1S)-1-(carboxymethyl)-3-fluoro-2-oxopropyl]-L-alaninamide,Peptide-like,Inhibitor,Yes,CYS145 A,None,None,None,None
7z4s,Crystal structure of SARS-CoV-2 Mpro in complex with cyclic peptide GM4 including unnatural amino acids.,3C-like proteinase nsp5,2,"A,B",306,Yes,"PEG
DMS
EDO
PGE",,(ACE)(DTY)FH(II7)LNLGYRPGC(NH2),Macrocyclic peptide inhibitor,polypeptide(L),,No,,None,None,None,None
3w37,Sugar beet alpha-glucosidase with acarbose,Alpha-glucosidase,1,A,913,Yes,"ACY
GOL
SO4
NAG",,"2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose,
alpha-L-fucopyranose-(1-3)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)]2-acetamido-2-deoxy-beta-D-glucopyranose,
PRD_900007","2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose,
alpha-L-fucopyranose-(1-3)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)]2-acetamido-2-deoxy-beta-D-glucopyranose,
4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-alpha-D-glucopyranose-(1-4)-alpha-D-glucopyranose-(1-4)-alpha-D-glucopyranose","oligosaccharide,
oligosaccharide,
Oligosaccharide","

Inhibitor","(N-Glycosylation)
(N-Glycosylation)
No","ASN823 A
ASN404 A
",None,None,None,None
8ddl,SARS-CoV-2 Main Protease (Mpro) H163A Mutant Apo Structure,"ORF1a polyprotein
ORF1a polyprotein",2,"A,B","306, 306",No,"PGE
NA
PEG
EDO",,,,,,,,"None
None","None
None","None
None","None
None"
7wq9,Crystal structure of SARS-CoV-2 main protease in complex with Z-IETD-FMK,3C-like proteinase,1,A,307,Yes,,,(P6S)I(GME)T(FL6)(CF0),Z-IETD-FMK,polypeptide(L),,Yes,CYS145 A,None,None,None,None
6lu7,The crystal structure of COVID-19 main protease in complex with an inhibitor N3,3C-like proteinase,1,A,306,Yes,,,PRD_002214,"N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~-((1R,2Z)-4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN-3-YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE",Peptide-like,Inhibitor,Yes,CYS145 A,None,None,None,None
7wq8,Crystal structure of SARS-CoV-2 main protease in complex with Z-DEVD-FMK,3C-like proteinase,1,A,307,Yes,,,(P6S)(FL6)(GME)V(FL6)(CF0),Z-DEVD-FMK,polypeptide(L),,Yes,CYS145 A,None,None,None,None
7nij,SARS-CoV-2 main protease (Mpro) in a novel conformational state.,3C-like proteinase nsp5,1,A,306,No,,,,,,,,,None,None,None,None
5r8t,"PanDDA analysis group deposition of ground-state model of SARS-CoV-2 main protease screened against DSI poised (Enamine), Fraglites and Peplites (Newcastle university), Mini Frags (Astex), York 3D (York university), electrophile cysteine covalent (Weizman institute) fragment libraries",3C-like proteinase,1,A,306,No,DMS,,,,,,,,None,None,None,None
6xa4,Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with UAW241,3C-like proteinase,1,A,308,Yes,GOL,,PRD_002391,inhibitor UAW241,Oligopeptide,Inhibitor,Yes,CYS145 A,None,None,None,None
7mb6,SARS-CoV-2 Main Protease (Mpro) C145A in Complex with Cleavage Site Nsp6/7 (P6-P1),3C-like proteinase,2,"A,B",306,Yes,,,KVATVQ,LYS-VAL-ALA-THR-VAL-GLN,polypeptide(L),,No,,None,None,None,None
8drs,Product structure of SARS-CoV-2 Mpro C145A mutant in complex with nsp6-nsp7 (C6) cut site sequence,3C-like proteinase nsp5,3,"A,B,C",306,No,,,,,,,,,None,None,None,None
1e03,PLASMA ALPHA ANTITHROMBIN-III AND PENTASACCHARIDE,ANTITHROMBIN-III,2,"A,B",432,Yes,NAG,,"2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose,
beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose,
PRD_900031","2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose,
beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose,
3,4-di-O-methyl-2,6-di-O-sulfo-alpha-D-glucopyranose-(1-4)-2,3-di-O-methyl-beta-D-glucopyranuronic acid-(1-4)-2,3,6-tri-O-sulfo-alpha-D-glucopyranose-(1-4)-3-O-methyl-2-O-sulfo-alpha-L-idopyranuronic acid-(1-4)-methyl 2,3,6-tri-O-sulfo-alpha-D-glucopyranoside","oligosaccharide,
oligosaccharide,
Oligosaccharide","

Anticoagulant","(N-Glycosylation)
(N-Glycosylation)
No","ASN96 A
ASN155 A; ASN155 B; ASN192 B
",None,None,None,None
8gvy,SARS CoV-2 Mpro in complex with D-3-149,3C-like proteinase nsp5,1,A,306,Yes,,,(ACY)AI(0A9),"3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.]PYRAZOLE",polypeptide(L),,Yes,CYS145 A,None,None,None,None
7rnw,SARS-CoV-2 Main Protease in complex with a cyclic peptide inhibitor,3C-like proteinase,4,"A,B,C,D",306,Yes,,,(ACE)(DTY)LQYAVLRHKRRE(9OW),ACE-DTY-LEU-GLN-TYR-ALA-VAL-LEU-ARG-HIS-LYS-ARG-ARG-GLU-SEC,polypeptide(L),,No,,None,None,None,None
6r0x,The extracellular domain of G6b-B in complex with Fab fragment and DP12 heparin oligosaccharide.,"antibody fab fragment heavy chain
antibody fab fragment light chain
Megakaryocyte and platelet inhibitory receptor G6b",6,"A,C,B,D,E,F","240, 234, 116",Yes,,,"beta-D-galactopyranose-(1-3)-[N-acetyl-alpha-neuraminic acid-(2-6)]2-acetamido-2-deoxy-alpha-D-galactopyranose,
2-O-sulfo-alpha-L-idopyranuronic acid-(1-4)-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranose-(1-4)-2-O-sulfo-alpha-L-idopyranuronic acid-(1-4)-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranose-(1-4)-2-O-sulfo-alpha-L-idopyranuronic acid-(1-4)-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranose-(1-4)-2-O-sulfo-alpha-L-idopyranuronic acid-(1-4)-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranose,","beta-D-galactopyranose-(1-3)-[N-acetyl-alpha-neuraminic acid-(2-6)]2-acetamido-2-deoxy-alpha-D-galactopyranose,
2-O-sulfo-alpha-L-idopyranuronic acid-(1-4)-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranose-(1-4)-2-O-sulfo-alpha-L-idopyranuronic acid-(1-4)-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranose-(1-4)-2-O-sulfo-alpha-L-idopyranuronic acid-(1-4)-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranose-(1-4)-2-O-sulfo-alpha-L-idopyranuronic acid-(1-4)-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranose,","oligosaccharide,
oligosaccharide,","
","(O-Glycosylation)
No","THR73 E; THR73 F
","None
None
None","None
None
None","None
None
None","None
None
None"
